Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study)
Category (Adult, Pediatric):
AdultLocation:
Washington D.C.Phase:
2Sponsor:
ONO Pharma USA, Inc.Description:
This study will evaluate tirabrutinib treatment in patients with Primary Central Nervous System Lymphoma (PCNSL).Last updated January 20, 2023
